Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Nathaniel Brennen

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Cancer Cell|October 11, 2017
Cellular Origin of Androgen Receptor Pathway-Independent Prostate Cancer and Implications for TherapyW Nathaniel Brennen, John T Isaacs
Nature Reviews. Urology|September 15, 2018
Mesenchymal stem cells and the embryonic reawakening theory of BPHW Nathaniel Brennen, John T Isaacs
The Prostate|March 26, 2018
The what, when, and why of human prostate cancer xenograftsW Nathaniel Brennen, John T Isaacs
Cancer Research|April 22, 2014
Enhancement of the T-cell armamentarium as a cell-based therapy for prostate cancerW Nathaniel Brennen, Charles G Drake, John T Isaacs
Nature Cancer|May 27, 2022
There are gremlins in prostate cancerLaura A Sena, W Nathaniel Brennen, John T Isaacs
Cell Cycle (Georgetown, Tex.)|August 19, 2017
Rationale for bipolar androgen therapy (BAT) for metastatic prostate cancerJohn T Isaacs, W Nathaniel Brennen, Samuel R Denmeade
Molecular Cancer Therapeutics|February 11, 2012
Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategyW Nathaniel Brennen, John T Isaacs, Samuel R Denmeade
Endocrine-Related Cancer|August 27, 2013
Mesenchymal stem cells as a vector for the inflammatory prostate microenvironmentW Nathaniel Brennen, Samuel R Denmeade, John T Isaacs
The Prostate|January 7, 2016
Rapid selection of mesenchymal stem and progenitor cells in primary prostate stromal culturesW Nathaniel Brennen, L Nelleke Kisteman, John T Isaacs
Annals of Translational Medicine|February 5, 2020
Serial bipolar androgen therapy (sBAT) using cyclic supraphysiologic testosterone (STP) to treat metastatic castration-resistant prostate cancer (mCRPC)John T Isaacs, W Nathaniel Brennen, Samuel R Denmeade
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Cancer Cell|October 11, 2017
Cellular Origin of Androgen Receptor Pathway-Independent Prostate Cancer and Implications for TherapyW Nathaniel Brennen, John T Isaacs
Nature Reviews. Urology|September 15, 2018
Mesenchymal stem cells and the embryonic reawakening theory of BPHW Nathaniel Brennen, John T Isaacs
The Prostate|March 26, 2018
The what, when, and why of human prostate cancer xenograftsW Nathaniel Brennen, John T Isaacs
Cancer Research|April 22, 2014
Enhancement of the T-cell armamentarium as a cell-based therapy for prostate cancerW Nathaniel Brennen, Charles G Drake, John T Isaacs
Nature Cancer|May 27, 2022
There are gremlins in prostate cancerLaura A Sena, W Nathaniel Brennen, John T Isaacs
Cell Cycle (Georgetown, Tex.)|August 19, 2017
Rationale for bipolar androgen therapy (BAT) for metastatic prostate cancerJohn T Isaacs, W Nathaniel Brennen, Samuel R Denmeade
Molecular Cancer Therapeutics|February 11, 2012
Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategyW Nathaniel Brennen, John T Isaacs, Samuel R Denmeade
Endocrine-Related Cancer|August 27, 2013
Mesenchymal stem cells as a vector for the inflammatory prostate microenvironmentW Nathaniel Brennen, Samuel R Denmeade, John T Isaacs
The Prostate|January 7, 2016
Rapid selection of mesenchymal stem and progenitor cells in primary prostate stromal culturesW Nathaniel Brennen, L Nelleke Kisteman, John T Isaacs
Annals of Translational Medicine|February 5, 2020
Serial bipolar androgen therapy (sBAT) using cyclic supraphysiologic testosterone (STP) to treat metastatic castration-resistant prostate cancer (mCRPC)John T Isaacs, W Nathaniel Brennen, Samuel R Denmeade
Pageof 7